Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.33
Data as of Jan 27
 -0.02 / -1.48%
Today’s Change
1.27
Today|||52-Week Range
3.18
-4.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues13.5M15.2M21.7M22.4M
 
 
 
 
 
 
Operating ExpensesGross Income6.2M5.1M9.1M9.3M
 
 
 
 
 
Total Operating Expenses48.2M57.3M50.0M58.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-34.7M-42.1M-28.4M-35.7M
 
 
 
 
 
Extraordinary Charge0.000.00-1.7M0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-34.2M-42.1M-29.8M-35.4M
 
 
 
 
 
Preferred Dividend0.000.000.00-401.0K
 
 
Net Income-34.2M-42.1M-29.8M-35.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.9M83.6M120.4M161.6M
 
 
 
 
 
Shares To Calculate EPS Diluted60.9M83.6M120.4M161.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.56-$0.50-$0.25-$0.22
 
 
 
 
 
EPS Diluted----------
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.